Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.

Waki H, Kagitani H, Osaga S, Inoue M, Yabe D

Open source

DOI
10.1007/s13300-026-01916-x
Published
2026 Sep 8
Container
Diabetes therapy : research, treatment and education of diabetes and related disorders
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13300-026-01916-x,
  title = {Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.},
  author = {Waki H and Kagitani H and Osaga S and Inoue M and Yabe D},
  year = {2026},
  journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  doi = {10.1007/s13300-026-01916-x},
  url = {https://doi.org/10.1007/s13300-026-01916-x}
}

RIS

TY  - JOUR
TI  - Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.
AU  - Waki H
AU  - Kagitani H
AU  - Osaga S
AU  - Inoue M
AU  - Yabe D
PY  - 2026
JO  - Diabetes therapy : research, treatment and education of diabetes and related disorders
DO  - 10.1007/s13300-026-01916-x
UR  - https://doi.org/10.1007/s13300-026-01916-x
ER  - 

APA

H, W., H, K., S, O., M, I., & D, Y. (2026). Tirzepatide Benefit for Early Glycemic and Weight Management in People with T2D in Japan: Rationale, Design, and Baseline Characteristics of T-BEAT Study.. Diabetes therapy : research, treatment and education of diabetes and related disorders. https://doi.org/10.1007/s13300-026-01916-x

Source records